Echocardiographic and Clinical Outcomes of Concomitant Secondary Chordal Cutting to Surgical Myectomy in Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-analysis

Abstract

In patients who underwent surgical myectomy for hypertrophic obstructive cardiomyopathy (HOCM), additional mitral valve repair may offer additional benefits in terms of further reducing left ventricular outflow tract (LVOT) gradients, systolic anterior motion (SAM), and mitral regurgitation (MR). We performed a systematic review of the literature to evaluate the evidence of surgical myectomy with additional secondary chordal cutting in patients with HOCM. A systematic literature search in MEDLINE and EMBASE was performed until April 2024. The primary outcome studied was postoperative echocardiographic LVOT gradient. A random effects meta-analysis of means was performed for the primary outcome. The secondary outcomes studied were postoperative residual MR grade, 30-day new permanent pacemaker implantation, and in-hospital mortality. From 1,911 unique publications, a total of 6 articles fulfilled the inclusion criteria and comprised 471 patients with a pooled mean preoperative resting LVOT gradient of 84 mm Hg (95% confidence interval [CI]: 76–91). The postoperative pooled mean LVOT gradient was 11 mm Hg (95% CI: 10–12) with a low heterogeneity (I ² = 44%). The residual LVOT gradient exceeding 30 mm Hg was present in nine (1%) patients. MR grade 3 or 4 at hospital discharge was present in seven (1%) patients. The 30-day new permanent pacemaker implantation rate was 7% and the in-hospital mortality was 0.4%. This systematic review and meta-analysis demonstrate that combining surgical myectomy with secondary chordal cutting can be performed safely and effectively eliminate LVOT obstruction in HOCM patients. Further studies are needed to determine the additive effectiveness of additional secondary chordal cuttings.

Keywords

cardiomyopathy - echocardiography (all modalities applications) - heart valve surgery - mitral valve surgery

• References

• 1 Arbelo E, Protonotarios A, Gimeno JR. et al; ESC Scientific Document Group. 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J 2023; 44 (37) 3503-3626
• 2 Michels M, Olivotto I, Asselbergs FW, van der Velden J. Life-long tailoring of management for patients with hypertrophic cardiomyopathy : awareness and decision-making in changing scenarios. Neth Heart J 2017; 25 (03) 186-199
• 3 Patel P, Dhillon A, Popovic ZB. et al. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy patients without severe septal hypertrophy: implications of mitral valve and papillary muscle abnormalities assessed using cardiac magnetic resonance and echocardiography. Circ Cardiovasc Imaging 2015; 8 (07) e003132
• 4 Guigui SA, Torres C, Escolar E, Mihos CG. Systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: a narrative review. J Thorac Dis 2022; 14 (06) 2309-2325
• 5 Tao J, Duan F, Long J. et al. The role of the submitral apparatus in hypertrophic obstructive cardiomyopathy. J Am Soc Echocardiogr 2023; 36 (02) 133-145
• 6 Yu EHC, Omran AS, Wigle ED, Williams WG, Siu SC, Rakowski H. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. J Am Coll Cardiol 2000; 36 (07) 2219-2225
• 7 Hong JH, Schaff HV, Nishimura RA. et al. Mitral regurgitation in patients with hypertrophic obstructive cardiomyopathy: implications for concomitant valve procedures. J Am Coll Cardiol 2016; 68 (14) 1497-1504
• 8 Kofflard MJ, van Herwerden LA, Waldstein DJ. et al. Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 1996; 28 (01) 197-202
• 9 Delmo Walter EM, Javier MF, Hetzer R. Long-term outcome of simultaneous septal myectomy and anterior mitral leaflet retention plasty in hypertrophic obstructive cardiomyopathy: the Berlin experience. Ann Cardiothorac Surg 2017; 6 (04) 343-352
• 10 Alfieri O, Maisano F, De Bonis M. et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001; 122 (04) 674-681
• 11 Hegeman RRMJJ, Heeringa T, Beukers SHQ. et al. Adding surgical edge-to-edge mitral valve repair to myectomy in hypertrophic obstructive cardiomyopathy: long-term functional and echocardiographic outcome. Curr Probl Cardiol 2024; 49 (1, Pt C): 102134
• 12 Ferrazzi P, Spirito P, Iacovoni A. et al. Transaortic chordal cutting: mitral valve repair for obstructive hypertrophic cardiomyopathy with mild septal hypertrophy. J Am Coll Cardiol 2015; 66 (15) 1687-1696
• 13 Page MJ, McKenzie JE, Bossuyt PM. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71
• 14 Maron MS, Olivotto I, Harrigan C. et al. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation 2011; 124 (01) 40-47
• 15 Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339 (01) b2535
• 16 Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 2019; 22 (04) 153-160
• 17 Zyrianov A, Spirito P, Abete R. et al. Impact of secondary mitral valve chordal cutting on valve geometry in obstructive hypertrophic cardiomyopathy with marked septal hypertrophy. Eur Heart J Cardiovasc Imaging 2023; 24 (05) 678-686
• 18 Dorobantu LF, Iosifescu TA, Ticulescu R. et al. Transaortic shallow septal myectomy and cutting of secondary fibrotic mitral valve chordae: a 5-year single-center experience in the treatment of hypertrophic obstructive cardiomyopathy. J Clin Med 2022; 11 (11) 3083
• 19 Ram E, Schwammenthal E, Kuperstein R. et al. Secondary chordal resection with septal myectomy for treatment of symptomatic obstructive hypertrophic cardiomyopathy. Eur J Cardiothorac Surg 2021; 60 (03) 699-707
• 20 Bogachev-Prokophiev A, Afanasyev AV, Zheleznev S. et al. Septal myectomy with vs without subvalvular apparatus intervention in patients with hypertrophic obstructive cardiomyopathy: a prospective randomized study. Semin Thorac Cardiovasc Surg 2019; 31 (03) 424-431
• 21 Afanasyev AV, Bogachev-Prokophiev AV, Zheleznev SI, Sharifulin RM, Zalesov AS, Budagaev SA. Edge-to-edge repair versus secondary cord cutting during septal myectomy in patients with hypertrophic obstructive cardiomyopathy: a pilot randomised study. Heart Lung Circ 2021; 30 (03) 438-445
• 22 Alashi A, Smedira NG, Hodges K. et al. Outcomes in guideline-based class I indication versus earlier referral for surgical myectomy in hypertrophic obstructive cardiomyopathy. J Am Heart Assoc 2021; 10 (01) e016210
• 23 Hodges K, Rivas CG, Aguilera J. et al. Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center. J Thorac Cardiovasc Surg 2019; 157 (06) 2289-2299
• 24 Kotkar KD, Said SM, Dearani JA, Schaff HV. Hypertrophic obstructive cardiomyopathy: the Mayo Clinic experience. Ann Cardiothorac Surg 2017; 6 (04) 329-336
• 25 Rastegar H, Boll G, Rowin EJ. et al. Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience. Ann Cardiothorac Surg 2017; 6 (04) 353-363
• 26 Nguyen A, Schaff HV, Nishimura RA. et al. Does septal thickness influence outcome of myectomy for hypertrophic obstructive cardiomyopathy?. Eur J Cardiothorac Surg 2018; 53 (03) 582-589